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Abstract
Background: Protein-protein interactions can be considered the basic skeleton for living
organism self-organization and homeostasis. Impressive quantities of experimental data are being
obtained and computational tools are essential to integrate and to organize this information. This
paper presents Protopia, a biological tool that offers a way of searching for proteins and their
interactions in different Protein Interaction Web Databases, as a part of a multidisciplinary initiative
of our institution for the integration of biological data http://asp.uma.es.
Results: The tool accesses the different Databases (at present, the free version of Transfac, DIP,
Hprd, Int-Act and iHop), and results are expressed with biological protein names or databases
codes and can be depicted as a vector or a matrix. They can be represented and handled
interactively as an organic graph. Comparison among databases is carried out using the Uniprot
codes annotated for each protein.
Conclusion: The tool locates and integrates the current information stored in the aforemen-
tioned databases, and redundancies among them are detected. Results are compatible with the
most important network analysers, so that they can be compared and analysed by other world-
wide known tools and platforms. The visualization possibilities help to attain this goal and they are
especially interesting for handling multiple-step or complex networks.
Background
A living organism is an open system that is constantly
exchanging chemical compounds, energy and
information with its environment. This exchange
involves a large number of elements (molecules) related
to each other in a dynamic hierarchical and modular
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Open Accessmanner. Modules can be identified from the analysis of
the interaction patterns. At a molecular level, interacting
networks include protein-protein interactions, metabolic
pathways, and the different biosignalling pathways
controlling intercellular cross-talk and the regulation of
gene expression [1,2]. Thus, protein-protein interactions
can be considered as the basic skeleton for living
organism self-organization and homeostasis [3]. Conse-
quently, understanding the structural data concerning
network skeletons, as well as its one-to-one element
interactions, is essential (though just beginning) for
effective progress in the characterization of biological
complex systems and in understanding the pathological
consequences of alterations in the properties of a given
node (protein). In fact, molecular interaction networks
are widely studied to reveal the complex roles played by
gene products and cellular environments in biological
and pathological processes [4-6].
When a new interactome is built with current informa-
tion integration tools, nodes represent macromolecules
and connecting segments represent specific interactions.
Nodes are associated with additional information about
the genes/proteins; for instance, chromosome number
and gene location, intracellular location of the protein,
and codes for locations in different Data Banks and
ontologies. All this information is extensively stored in
several data warehouses (Expasy, Gene Bank, Uniprot, or
Gene Ontology, among others) [7-10].
Multiple sources of information on protein to protein
interaction exist. They have usually been analyzed indivi-
dually by genetic, biochemical and biophysical techniques.
Recently, however, new methods have been developed for
high-throughput macromolecular interaction analysis,
including both experimental and biocomputational
approaches. The high speed of new data generation has
causedaproblem,namelystandardizationof itsnotationin
database(s) [11]. In the most significant interaction
databases, the information provided by these methods is
stored, curated and commonly linked to node data ware-
houses, but many details are not always fully or clearly
specified (for instance, type of interaction, experimental
conditions, etc). This lack of precision in interaction
description is a major problem of the high-throughput
data repositories. Further efforts are therefore essential to
improve the quality of the protein-protein interaction
databases to reach a level of confidence on crude networks,
to save manual curation efforts and, consequently, to gain
efficiency in inferring useful biological information from
the interactome graphs. In addition, intersection and
overlapping among these databases is limited and, there-
fore, the information is complementary in many cases.
Thus, information should be unified to increase and to
improveknowledgeaboutinteractionnetworks.Inthisway,
several databases are working to integrate all this informa-
tion on flexible platforms: BiologicalNetwork, Agile Protein
Interaction Data-Analyzer (APID), KEGG or Protein Launge
[12-14]. Finally, even partial interactomes on a given
intracellular process often contains hundreds of nodes
which are difficult to manage during analysis. Conse-
quently, efforts to improve result visualization and compat-
ibility among different platforms would also be helpful.
In this paper, we present a tool called Protopia for
searching for and integrating protein-protein interactions
and the information about them contained in five different
Protein Interaction Web Databases. It can be useful as a
friendly search interface among different databases, as a
validator of redundant information, as a network visuali-
zation tool and also as an export tool to SBML [15].
Methods
Protopia is a modularized application, with separate
functionalities providing a high degree of reusability and
error correction. There are several main modules (Figure 1)
that work together but are built separately with a different
functionality: Graphic User Interface, Model, Visualization
Engine, Search Engine Interface, Data Source Adapter Interface
and Data Source Extractor Interface. Protopia has been
implemented in Java because it makes it possible to
manage all required software patterns and also provides
Operative System independence. Protopia components
have been designed to increase reusability and the
possibility of including new databases when required.
The description of these components is shown below:
￿ The Graphic User Interface: A user interface is
provided to use and to manage all the capabilities
of Protopia in an easy manner.
Figure 1
Protopia's architecture. The diagram of Protopia's
architecture shows the decoupling between all their
components.
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other components, and makes cooperation amongst
them possible.
￿ Visualization Engine: It provides diverse representa-
tions of the located protein to protein interactions. Two
kinds of text representations (vector and matrix), and
two kinds of graph representations (hierarchical and an
organic hypergraph) have been implemented using a
hypergraph [16] library and the Graphviz [17] library.
￿ Search Engine Interface:I tu s e st h eData Source
Adapter Interface of every Data Service implemented to
perform the specific search among the data sources
included in Protopia.
￿ Data Source Adapter Interface: An abstract interface
defined to be implemented by a custom data source
extractor in order to be able to both communicate and
cooperate with the Search Engine Interface. It describes
some basic operations to implement the service.
￿ Data Source Extractor Interface: An abstract interface
defined to be implemented by a custom data source
extractor in order to be able to transform the original
data to a common data structure usable by the Search
Engine Interface.
Data source extractors
The data source extractors are the components capable of
extracting and transforming the protein interaction
information. They implement the Data Source Adapter
I n t e r f a c ea n dt h eD a t aS o u r c eE xtractor Interface required
to make them compatible with Protopia (Figure 2).
This project has been implemented with five data source
extractors from five main Protein Web Databases (the
free version of Transfac, DIP, Hprd, Int-Act and iHop) by
using an access via HTTP. It was achieved by implement-
ing parses among the HTTP text. Thus, our tool is able to
use an abstract interface that defines the extraction and
adaptation of the data by applying a usual data
extraction method (via HTTP parse), but it can also be
deployed by using direct access to databases (via FTP),
web services, and other available data access.
When a data source extractor is needed, it is easy to provide
a new one by extending two java classes, one to define the
URLs and characteristics (Data Source Adapter Interface)
and the other one to define the way to obtain the different
nodes and interactions of the graphs (Data Source Extractor
Interface). In the same way, it is possible to build custom
data source extractors for a desirable data source without
the need to recompile the source code, in other words
simply by packaging those two implemented classes, by
creating a simple jar, and by copying it in an interface
folder. Protopia automatically detects the changes in the
folder and loads the new data source extractor.
Data representation and interoperability
Most efforts in Protopia have been directed to providing
useful and friendly protein interaction graph representa-
tions. In Protein to Protein interaction graph visualization
a perfect visualization method does not exist, but there
are applications that achieve it with a moderate to high
degree of satisfaction. That is the case of ProViz, iPfam or
Cytoscape [18-20]. Since protein to protein graphs tend to
be very big, you have to choose either to have a global
representation of the graph or to have a detailed
representation of a part of the graph. For these reasons,
we consider to improve two different visualization ways
that full equip Protopia as a complete interaction viewer.
Four different kinds of visualization have been imple-
mented. In all cases proteins can be represented by either
t h ea b b r e v i a t e dn a m eo rt h ec o d eo ft h er e s p e c t i v eD a t a
Bank:
￿ The first one is based on a text vector form (Figure 3)
and the second one is based on a text matrix form
(Figure 4). They have been implemented in text mode
to provide a simple and low load mode that allows
copying and pasting the results easily.
￿ T h et h i r do n ei sb a s e do nt h eG r a p h v i z[ 1 7 ]l i b r a r y ,
which provides a hierarchic and schematic point of
view of the interaction graph and enables the user to
analyse the graph in a global way. Implementation of
the Graphviz view mode is simple and it only makes
external calls to the Graphviz package (Figure 5).
￿ The fourth one has been implemented on the basis of
anorganichypergraphlibrary[16],whichprovidesafish
eye view and makes it easier to analyse the net based on
a main protein and its interacting neighbourhood
(Figure 6). This visualization method enables the user
to interact with the graph and change it (organically) to
centre the view on the desired area, which is extremely
useful for analysing a specific part of the graph.
Implementation was carried out by extending the
corresponding java classes to reach the desirable
functionalities. Since our tool is able to manage up
to more than one thousand nodes of a several-step
network, this visualization is particularly convenient and
helpful for complex network visualization and analysis.
On the other hand, an optimum system should be able
to reach a high degree of integration with any informa-
tion repository, as well as maximum interoperability
among the different data analysis tools. In our system
integration of a new Data source will be easily executed
by following the same procedure described above.
Reciprocally, the information collected by our tool can
be recorded in a file, saving the interaction data graph in
plain text mode or in the standard SBML format, making
results compatible with many otherplatforms (for
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comparative analysis of different networks.
Detection of redundancies
An optimum system should be able to locate and unify
the information on a given molecule stored under any of
its identifiers and return a confidence value to the user
for each located edge.
The increasing activity of the scientific community in
applying technologies feeding protein-protein interac-
tion information (for instance, bioinformatics
predictions from HTP-technologies, 2-hybrids, pool-
down, fluorescence correlation spectroscopy, fluores-
cence resonance energy transfer), followed by their
notations in Data Banks, makes it likely that information
on protein-protein interactions will grow exponentially
in the short-term. It would be convenient that such a
volume of information could be discriminated to select
the most relevant in order to avoid an undesirable
increase of background. Multiple facts should be taken
into account for an accurate estimation of confidence;
for instance, the method(s) used to deduce such an
interaction (in silico, in vitro and/or in vivo). This
Figure 2
Data source extraction scheme. Abstract classes A and B define the operations required and implement the functionality
between them. Scheme shows the class diagram which represents the extraction's implementation in IHOP. For other sources
classes C and D are different.
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different technologies and their values integrated in a
“global confidence score algorithm” is not an easy task,
and may be premature. In our opinion, such an
algorithm should be reached by consensus and its cut-
off should be selected by the user, which could be
particularly important for studies of poorly-characterized
interactomes.
At the present stage, with this goal in mind and taking
into account the heterogeneous information captured by
the different repositories and the dynamics of new
inputs, a simple (but slanted) approach to the final
Figure 4
Text matrix implementation. The figure shows the results obtained from DIP for P53 [DIP:368] [SwissProt:P04367]. This
kind of data representation was thought to simplify the view of interactions in text mode.
Figure 5
Graphviz visual implementation. The figure shows the
results obtained from DIP for P53 [DIP:368] [SwissProt:
P04367]. This kind of graph view had a hierarchical layout
capability, used to see the interactions by his level.
Figure 3
Text vector implementation. The figure shows the results obtained from DIP for P53 [DIP:368] [SwissProt:P04367]. This
kind of data representation was thought to allow experimented biologist to obtain a file with plain text as target for a program
input.
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number of repositories-containing information on the
interaction and the total number of queried databases. In
our tool, this quotient is called “redundancy”.
Redundancy algorithm and values
The Protopia algorithm to look for redundancy is based
on a simple but efficient search across all the available
data sources (see Figure 7). The tool validates every pair
of proteins this way: For every pair obtained from one of
the data bases (for instance, DIP), we obtain the
respective Swissprot codes (step C in Figure 7). Then,
both protein codes are the parameter to search for the
corresponding identifier code of every other data source
(step D in Figure 7). Once both identifiers are available,
an interaction between these two codes is performed in
every data source. The original database where the
interaction was first detected is not taken into account
in the quotient.
Then, Protopia can validate those interactions searching
among all the integrated databases, looking for those
relationships in all the databases and retrieving the
validation for the user. This is called the redundancy
factor. Depending on the visualization mode, the results
are expressed as quotients on the edges and/or by a three
colour code for the edges (see Example of Redundancy
Value Section). Thus, high redundancy (the darkest
edges) will be considered when the numerator is as big
as the denominator. It means that the interaction is
redundantly defined in all the databases used in
Protopia. No redundancy (the lightest edges) will be
considered when the numerator is one. It means that the
interaction is defined only in the original database and
Figure 6
Hypergraph visual implementation.I nAt h ev i e wi sc e n t e r e do v e rt h eP 5 3p r o tein [DIP:368] [SwissProt:P04367]. In B
the view is centered over the p53-binding protein Mdm2 [DIP:24224N] [SwissProt:Q00987].
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other databases. Medium redundancy will be considered
in other cases. It means that the interaction is defined
in some (more than one) of the databases used in
Protopia.
Example of redundancy value
This example shows an example of a single step search of a
well known suppressor gene product, p53, described as a
hub by several authors, including our own results [21,22].
In DIP, it is described as “cellular tumor antigen P53”,w i t h
DIP code “368”. For this protein, 37 interaction pairs were
found.
The interaction redundancy hypergraph of the other data
sources implemented in Protopia (Transfac Web, Intact,
HPRP, IHOP) was analysed and is shown in Figure 8. It
is obvious that one of the data sources could not locate
or obtain the Swiss-Prot code of the protein P53 [Swiss-
Prot: P04637] in their database, because the maximum
denominator is 3 and the number of databases
compared was four. For this reason we believe that is
important to use Web services instead of HTTP access.
However, most of the databases do not provide this kind
of interface. Another reason for a lower redundancy is
because we use Transfac Web that does not allow access
to all its proteins in the free version.
In this example, only 62.16% of the protein interactions
were redundant to some extent. Of this percentage,
only 10.81% of the interactions are described in three of
the databases, 40.54% are described in two of the
databases, and 10.81% are described in just one of the
databases.
Results
Protopia is one of the biocomputational tools imple-
mented by the ASP project http://asp.uma.es. This
section will describe Protopia characteristics. Briefly,
Protopia provides a configuration tool for selecting the
database(s) used to retrieve information. Once the target
database(s) has been selected, users can search by either
t h en a m eo rt h ec o d eo ft h ed e s i r e dp r o t e i n ,a n di t
retrieves a list of proteins from which to choose the
required one. Once the protein is chosen, the tool will
search its interactions through the selected database(s),
and returns a collection of proteins and their interac-
t i o n s .T h er e s u l to fas e a r c hc a nb ev i s u a l i z e di nt h r e e
d i f f e r e n tw a y s :av e c t o r ,am a t r i x ,a n dag r a p h( F i g u r e9 ) ;
results can also be saved in text formats or in SBML
format. It is also possible to use logic operators to
compare the interactions between two specific proteins,
and to search all the paths between two proteins. By
default, the search ratio has just one level of interactions,
but it is a configurable option and the tool can show
interactions up to a 10-level deep tree. This tree-graph is
a way of showing protein interactions quickly and
efficiently, but it is also an interactive way of visiting
the web page where the tool has queried to obtain the
information. The visualization engine is an interactive
and navigable graph that offers a nice visualization of a
specific zone of the graph.
Protopia actually integrates five Web Protein Databases: the
free version of Transfac, DIP, Hprd, Int-Act and iHop
[23-27]. These are five of the most important interaction
protein databases existing at present, and we search all the
data through queries directly to the Web Server.
Figure 7
Redundancy analysis algorithm scheme.I ns t e pA a
network is captured from a given database. In step B,t h e
network is decomposed into its interaction pairs. In step C,
Protopia looks for the SwissProt code of both proteins of
every pair captured. In step D, the specific database code (for
each of the other databases) for the SwissProt code is
located. In step E, the interactions between the specific
codes of the pairs are located in all the other databases.
Finally, step F checks if the interaction has been found, and in
this case a unit is added to the redundancy factor numerator.
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been presented in previous sections. In summary,
looking for its interactions in Transfac we notice that
there are 36 interactions with other proteins (Figure 5).
But, users could be interested in looking for the
interactions of those 36 proteins with other proteins.
So, the interaction graph is expanded to the second level
(Figure 6). This graph can be also validated with respect
to the other databases. So, the user obtains the
redundancy factor as measure to quantify the real
possible probability of interaction, if it is desirable to
filter the huge quantity of interactions on an automatic
way to allow the expert to study only the more probably
interaction literature (Figure 8).
Figure 8
Redundancy analysis example. Redundancy analysis hypergraph of the “cellular tumor antigen” p53 network. The
redundancy of ribonucleotide reductase p53R2 chain is the highest possible, and we will expect a high interaction probability.
Figure 9
Visualization. 4-level-deep network visualization of p53 protein [DIP:368] [SwissProt:P04367] that involves a total number of
836 proteins and 1595 interactions. The Figure is centered on p53 and is represented by an interactive organic graph as
explained below.
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Protopia deals with integration problems caused by the
heterogeneity of Biological databases. For instance, there is
no universal identification code for proteins accepted by
the whole scientific community. Protopia tries to validate
interactions using the Swissprot code which is usually
available in most protein data files, matching them with
this code which is also available in Expasy. However, if for
example the user is using the HPRD engine, the Swissprot
code of the p53 regulated apoptosis inducing protein 1 is
not available (it is possible to visualize the problem by
visiting the page and looking for the empty Swiss-Prot field
in this HPRD web link: http://www.hprd.org/links?protei-
n=10397&isoform_id=10397_1&isoform_name=Iso-
form_1). Consequently, the redundancy quotients of any
interaction involving p53 are lacking the information
coming from HPRD. This problem is solved by analyzing
the known names or synonyms (or even the sequence)
when the Swissprot code is not available (due to an
annotation error or because the protein is not identified by
the Uniprot).
Protopia scores its results on the basis of the redundancies
in the interaction information among the different
repositories. Obtaining a higher redundancy level between
PPI databases is only a matter of time. However, for some
species like humans [28] a low redundancy level still exists
among the different databases. Currently, this inconve-
nience hampers the accuracy of any attempt geared at
computer-assisted validation of the results. Also, we are not
always able to find via HTTP the protein that belongs to a
Swiss-Prot code, because sometimes it is impossible to
query some parameters this way and the redundancy factor
could be lower because of this lack, this is the reason we
claim to databases to offer a best way to access data, like
web services. In our opinion, it is time to reach consensus
on a more unified way of making new annotations and to
have a score algorithm accepted by the scientific commu-
nity in order to help information integration and
interchange and to obtain maximum benefits from the
huge experimental efforts that are being carried out at
present. To evaluate the quality of the interaction, we agree
with the need to standardize and to score the annotations
regarding experimental methods, sources, etc used in the
described interaction, also claimed by other groups [1].
The access to data sources has been implemented via
HTTP, which could seem more expensive in time and
data transfer than other tools working on downloaded
information. In turn, our tool allows an easy online way
to access current data. Thus, the information obtained is
always up-to-date. In our approach, information loca-
tion problems will be solved when most of the public
databases develop a web service that allows us to ask for
just a given protein.
Conclusion
Protopia has become a useful tool to search for, visualize
and validate protein interactions, by providing an intuitive
user interface and useful configurability. This tool provides
multiple ways of representing the results, being useful for
researchers to quickly and efficiently find protein interac-
tions and long-distance protein-protein relationships. One
of Protopia’s best features is that it is designed to access
online data. Therefore, it is unnecessary to keep large
quantities of data (and periodically download the full
database). Only a little cache disk space is maintained to
provide quicker access to the interaction information. The
ease in implementing a new data source extractor interface
adds functionality and new sources to compare interac-
tions. The possibility of exporting the interactions to the
standard SBML format enables the reuse of the interaction
graph with other programs and tools. Thus, Protopia is not
just an end-user application; it can also be used as a protein
to protein interaction extractor capable of saving the
selected proteins and interactions in a SBML file for
subsequent analysis and manipulation.
Current databases offer a different level of curation,
annotation, number of proteins, and number of inter-
actions. We intend to continue working towards taking
all this information (and all future information) to offer
an improved interaction analysis method and tool able
to take into account new filters, as if they were the tissues
of an organism, and the experimental technology used to
obtain the information. In fact, we believe that in the
future (when enough information will have been
extracted and annotated) the ideal tool should be able
to detect and compare intercellular differences [29]. In
the short/medium-term (over the next 1–2y e a r s ) ,w ea r e
planning to develop a CellDesigner plug-in that incor-
porates the two Protopia visualizations, as well as
another plug-in that uses different access databanks to
evaluate and validate PPIs with the new ideas proposed.
It is accepted that this kind of biocomputational effort and
tool is essential for the advance of knowledge in Systems
Biology. Analyzing protein interaction networks using
structural information is one of these approaches [1]. In
particular, our group requires them as part of a dual in
silico-experimental strategy to study different biomedical
problems [30]. Cancer, inflammation/immunity problems
and orphan diseases are several of these biomedical
problems for which network characterizations could reveal
important emergent properties to understand and control
the frequently dramatic systemic consequences of altera-
tions in just a simple metabolic element. Important efforts
are being made in cancer and inflammation/immunity
problems [31-33] to advance in the knowledge and
intervention possibilities of these pathologies. Neverthe-
less, it is for orphan/rare diseases, many of them caused by
BMC Bioinformatics 2009, 10(Suppl 12):S17 http://www.biomedcentral.com/1471-2105/10/S12/S17
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maximum degree of information, mostly due to the scarce
number of human samples, as a result of which advance is
only possible by using experimental approaches [34,35].
Due to the complexity of the human organism and
different cell and tissue-specificities, it is almost impossible
to obtain a complete picture of the different syndromes at
the human level just by integrating the information
provided by studies carried out on the isolated protein
elements affected in each case, or by biochemical results
obtained with cultured cell type models. This task requires
systemic approaches, including the development of new in
silico tools not only to integrate information, but also to
filter and to organize the information obtained from many
thousands of experimental molecular, biochemical and
cellular studies in an automated way.
Characterization of protein networks, as well as for-
malization (mathematic modelling) of the metabolic
behaviour could help the scientific community in
searching for biochemical answers at the systemic level
for many pathologies, including orphan diseases. It
could allow us to predict the consequences of a given
alteration in one of the protein/gene elements involved
in a metabolic pathway, taking into account the cell
specificities of the different human tissues and cell types.
In fact, due to the differential expression patterns of the
different cell types, a similar genetic alteration can be
compensated or can have little importance in the
correct function of one cell type, whereas it could have
important consequences in the function of another one.
This approach can also be useful to obtain emergent
information on how to transmit the consequences of a
molecular alteration to other apparently long-distance
metabolic reactions of a given cell type, thus helping to
understand (at least partially) the biochemical causes
for the loss of homeostasis of patients. As evidenced in
the acknowledgement section and affiliation, our group
is engaged in different projects and networks (on cancer,
inflammation, angiogenesis, and rare diseases) with the
aim of contributing to a better understanding of the
m o l e c u l a rc a u s e so rc o n s e q u e n c e so fa n yo ft h e s e
pathologies and, consequently, to the design of new
and more efficient intervention strategies.
Availability and requirements
￿ Project name: Protopia, A protein-protein interac-
tion tool.
￿ Project home page: http://asp.uma.es/Protopia/
index.jsp
￿ Operating System: All which supports Java.
￿ Programming language:J a v a .
￿ Other requirements: Java SE 6.0, Graphviz to
visualize dot graphs.
￿ License: Creative Commons, http://creativecom-
mons.org/licenses/by-nc-nd/3.0/
￿ Manual: http://asp.uma.es/Protopia/resources/User
%20manual.pdf
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